Johnson & Johnson to compensate faulty hip implant patients in India

Johnson & Johnson (J&J) has agreed to work with the Indian government to offer compensation to patients who were affected by faulty hip implants.

Free Report

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:

A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
Medical device pricing data that can be tracked by market, company, and brand
Additional categories that can be built on a custom basis

Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.

By GlobalData

By clicking the Download Free Report button, you accept the terms and conditions and acknowledge that your data will be used as described in the GlobalData privacy policy

By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

DePuy International, a unit of J&J, sold the implant known as DePuy ASR in India before it was recalled in 2010 after data indicated they failed at a higher-than-expected rate.

“Johnson & Johnson has been recommended to pay a base compensation of Rs2m ($27842) to each patient.”

Last month the Central Drugs Standard Control Organization (CDSCO) asked the company to compensate all the patients who were fitted with articular surface replacement (ASR) implant.

The government -appointed committee recommended a base compensation of Rs2m ($27842) to each patient.

It is estimated that nearly 4,500 patients were fitted with the recalled device before they were recalled.

A Johnson & Johnson spokeswoman in a statement emailed to Reuters said: “We have always been and continue to be fully committed to supporting all ASR patients in India, and the rest of the world.

“In light of the recent committee report, we are seeking to work with the Indian government to develop an appropriate process for providing further support and compensation for patients in need,” she added.

However, there is no confirmation on whether the company will pay the recommended compensation to each patient or is in plans to negotiate the amount with the government, reported the news agency.

In 2013, Johnson & Johnson agreed to pay nearly $2.5bn in the US to settle thousands of lawsuits from patients who complained that they were affected by the implants.

Free Report

Find the right pricing strategy for your medical device

A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
Medical device pricing data that can be tracked by market, company, and brand
Additional categories that can be built on a custom basis

By GlobalData